Toosendanin
CAS No. 58812-37-6
Toosendanin ( —— )
产品货号. M18857 CAS No. 58812-37-6
川楝素对人早幼粒细胞白血病 HL-6 细胞的生长、细胞周期阻滞、诱导细胞凋亡以及相关信号通路有影响。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥169 | 有现货 |
|
| 5MG | ¥258 | 有现货 |
|
| 10MG | ¥364 | 有现货 |
|
| 25MG | ¥575 | 有现货 |
|
| 50MG | ¥824 | 有现货 |
|
| 100MG | ¥1197 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥447 | 有现货 |
|
生物学信息
-
产品名称Toosendanin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述川楝素对人早幼粒细胞白血病 HL-6 细胞的生长、细胞周期阻滞、诱导细胞凋亡以及相关信号通路有影响。
-
产品描述Toosendanin possesses hepatotoxicity. Toosendanin has effects on the growth, cell cycle arrest, induction of apoptosis and the involved signaling pathway in human promyelocytic leukemia HL-6 cells. Toosendanin is an effective insecticide for Ae.
-
体外实验——
-
体内实验Toosendanin (0.5 and 1 mg/kg, Intraperitoneal injection daily for 7 days) alleviates DSS-induced experimental colitis by inhibiting M1 macrophage polarization and regulating NLRP3 inflammasome and Nrf2/HO-1 signaling, and may provide a novel Chinese patent medicine for the treatment of murine colitis. Animal Model:Forty-eight male C57BL/6 mice weighing 20-22 g.Dosage:0.5 and 1 mg/kg.Administration:Intraperitoneal injection daily for 7 days.Result:Protected against DSS-induced colitis in mice.Inhibited the expression of proinflammatory cytokines in DSS-induced UC and improved oxidative stress.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number58812-37-6
-
分子量574.62
-
分子式C30H38O11
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (174.03 mM)
-
SMILESCC(=O)OC1CC(C23COC(C1(C2CC(C4(C3C(=O)C(C5(C46C(O6)CC5C7=COC=C7)C)OC(=O)C)C)O)C)O)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Candicine
Candicine 是来自 Stapelia gigantea 的天然产物。
-
Geniposidic Acid
京尼平苷酸是一种环烯醚萜苷,用于治疗炎症、黄疸和肝脏疾病。
-
Phthalic Acid Monooc...
用作医药中间体。
021-51111890
购物车()
sales@molnova.cn

